2-[4-[[2,4-dimethyl-5-[4-(2-propanoylphenyl)piperazine-1-carbonyl]phenyl]methyl]piperidin-1-yl]benzonitrile
C35H40N4O2 — CID 162042261
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[[2,4-dimethyl-5-[4-(2-propanoylphenyl)piperazine-1-carbonyl]phenyl]methyl]piperidin-1-yl]benzonitrile
2-[4-[[2,4-dimethyl-5-[4-(2-propanoylphenyl)piperazine-1-carbonyl]phenyl]methyl]piperidin-1-yl]benzonitrile (PubChem CID 162042261) has the molecular formula C35H40N4O2 and a molecular weight of 548.73 g/mol. Its IUPAC name is 2-[4-[[2,4-dimethyl-5-[4-(2-propanoylphenyl)piperazine-1-carbonyl]phenyl]methyl]piperidin-1-yl]benzonitrile.
Molecular Properties
| Compound Name | 2-[4-[[2,4-dimethyl-5-[4-(2-propanoylphenyl)piperazine-1-carbonyl]phenyl]methyl]piperidin-1-yl]benzonitrile |
|---|---|
| PubChem CID | 162042261 |
| Molecular Formula | C35H40N4O2 |
| Molecular Weight | 548.73 g/mol |
| Exact Mass | 548.32 |
| IUPAC Name | 2-[4-[[2,4-dimethyl-5-[4-(2-propanoylphenyl)piperazine-1-carbonyl]phenyl]methyl]piperidin-1-yl]benzonitrile |
| SMILES | CCC(=O)c1ccccc1N1CCN(C(=O)c2cc(CC3CCN(c4ccccc4C#N)CC3)c(C)cc2C)CC1 |
| InChI | InChI=1S/C35H40N4O2/c1-4-34(40)30-10-6-8-12-33(30)38-17-19-39(20-18-38)35(41)31-23-29(25(2)21-26(31)3)22-27-13-15-37(16-14-27)32-11-7-5-9-28(32)24-36/h5-12,21,23,27H,4,13-20,22H2,1-3H3 |
| InChIKey | YXKYFNYNVUGOER-UHFFFAOYSA-N |
| XLogP | 6.19 |
| TPSA | 67.65 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 548.73 |
| LogP ≤ 5 | 6.19 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162042261 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.